290 related articles for article (PubMed ID: 27164635)
1. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635
[No Abstract] [Full Text] [Related]
2. Etoricoxib-induced acute generalized exanthematous pustulosis.
Mäkelä L; Lammintausta K
Acta Derm Venereol; 2008; 88(2):200-1. PubMed ID: 18311467
[No Abstract] [Full Text] [Related]
3. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
Kumar S; Bhale G; Brar BK
Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
[No Abstract] [Full Text] [Related]
4. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K
J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643
[No Abstract] [Full Text] [Related]
5. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
Liu J; Li LF
J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
[TBL] [Abstract][Full Text] [Related]
6. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
[TBL] [Abstract][Full Text] [Related]
8. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
[TBL] [Abstract][Full Text] [Related]
9. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
Şikar Aktürk A; Bayramgürler D; Salman S; Yıldız KD; Odyakmaz Demirsoy E
Cutan Ocul Toxicol; 2014 Dec; 33(4):337-8. PubMed ID: 24938451
[TBL] [Abstract][Full Text] [Related]
10. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
Winnicki M; Shear NH
Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
[TBL] [Abstract][Full Text] [Related]
11. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
Powers R; Gordon R; Roberts K; Kovach R
Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
[TBL] [Abstract][Full Text] [Related]
12. Fixed drug eruption and generalised erythema following etoricoxib.
Augustine M; Sharma P; Stephen J; Jayaseelan E
Indian J Dermatol Venereol Leprol; 2006; 72(4):307-9. PubMed ID: 16880582
[No Abstract] [Full Text] [Related]
13. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) induced by amoxicillin-clavulanate.
Dogru M; Ozmen S; Ginis T; Duman H; Bostanci I
Pediatr Dermatol; 2012; 29(6):770-1. PubMed ID: 22044408
[TBL] [Abstract][Full Text] [Related]
14. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab.
Yang SY; Lan CC; Hu SC
Int J Dermatol; 2017 May; 56(5):571-572. PubMed ID: 28217835
[No Abstract] [Full Text] [Related]
15. Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.
Andrade P; Gonçalo M
Contact Dermatitis; 2011 Feb; 64(2):118-20. PubMed ID: 21210830
[No Abstract] [Full Text] [Related]
16. Oral mucosal involvement and petechial lesions: a SDRIFE case with unusual findings.
Karadag AS; Ozlu E; Akdeniz N; Uzuncakmak TK; Turkoglu Z; Ozkanli S; Zemheri E
Cutan Ocul Toxicol; 2016; 35(2):157-9. PubMed ID: 26339719
[TBL] [Abstract][Full Text] [Related]
17. Systemic drug-related intertriginous and flexural exanthema (SDRIFE).
Elmariah SB; Cheung W; Wang N; Kamino H; Pomeranz MK
Dermatol Online J; 2009 Aug; 15(8):3. PubMed ID: 19891911
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature.
Heck J; Stichtenoth DO; Mettin R; Jöckel J; Bickel C; Krichevsky B
Eur J Clin Pharmacol; 2021 Jan; 77(1):141-144. PubMed ID: 32761371
[No Abstract] [Full Text] [Related]
19. A case of fixed drug eruption induced by doxycycline, mimicking a symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
Favrelière S; Hosteing S; Jazeron JF; Allouchery M; Lafay-Chebassier C; Perault-Pochat MC
Therapie; 2020; 75(5):511-513. PubMed ID: 31761151
[No Abstract] [Full Text] [Related]
20. Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin.
Moreira C; Cruz MJ; Cunha AP; Azevedo F
An Bras Dermatol; 2017; 92(4):587-588. PubMed ID: 28954125
[No Abstract] [Full Text] [Related]
[Next] [New Search]